课题基金 / 基金详情

项目摘要

项目成果

Dirk Schnappinger的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Tuberculosis (TB) remains the second leading cause of human death from a single infectious agent. Mycobacterium tuberculosis strains that are resistant against multiple drugs (MDR) or are extremely drug resistant (XDR) continue to emerge and spread. New drugs are needed limit the impact of TB on global public health. We demonstrated that biotin metabolism is essential for growth and persistence of M. tuberculosis during infections, that biotin starvation can cause bacterial cell death, and we identified inhibitors of the biotin protein ligase of M. tuberculosis. In the proposed research we will (i) measure vulnerability of M. tuberculosis towards inhibition of different enzymes participating in biotin metabolism, (ii) identify triggers of biotin-starvation-induced cell death in M. tuberculosis, (iii) use structure-based drug design to further develop available lead compounds that inhibit biotin metabolism in M. tuberculosis, and (iv) study the mechanism of action of these inhibitors.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
2023 Tuberculosis Drug Discovery and Development Gordon Research Conference and Gordon Research Seminar
  • 批准号:
    10675238
  • 项目类别:
  • 资助金额:
    $0.6万
  • 财政年份:
    2023
  • 负责人:
    Dirk Schnappinger
  • 依托单位:
Project 2. Acquisition, synthesis and importance of biotin in Mtb.
Project 2. Acquisition, synthesis and importance of biotin in Mtb.
Project 2. Acquisition, synthesis and importance of biotin in Mtb.
海外基金